In previous studies the phosphorylation status of mTOR targets such as S6 protein from surrogate tissue or tumour samples has been commonly used as a marker of mTOR kinase activity and the degree of mTOR inhibition (Boulay et al, 2004; Duran et al, 2006). The gene discussed is MTOR; the disease is neoplasm.